Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $97,695 were sold by Boughton Soleil on Apr 28 ’25. At $30.19 per share, Boughton Soleil sold 3,236 shares. The insider’s holdings dropped to 159,662 shares worth approximately $8.21 million following the completion of this transaction.
Also, Dudum Andrew sold 50,000 shares, netting a total of over 1,819,310 in proceeds. Following the sale of shares at $36.39 each, the insider now holds 92,103 shares.
Before that, Dudum Andrew had sold 41,667 shares from its account. In a trade valued at $1,257,760, the Chief Executive Officer traded Hims & Hers Health Inc shares for $30.19 each. Upon closing the transaction, the insider’s holdings decreased to 41,667 shares, worth approximately $4.73 million.
As published in a research note from TD Cowen on April 29, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Hold and the price target has been revised to $30. Analysts at Morgan Stanley downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal-weight”‘ outlook in a report released in mid February. As of January 10, 2025, Citigroup has decreased its “Neutral” rating to a “Sell” for HIMS. Earlier on January 07, 2025, BTIG Research initiated its rating. Their recommendation was “a Buy” for HIMS stock.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 42.15%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 112.57%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $23.97 on 04/04/25. A 50-day SMA is recorded $33.62, while a 200-day SMA reached $27.56.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 49.38, which, if violated, would cause prices to drop to 47.35. In the upper region, resistance lies at 54.09. The next price resistance is at 56.77. RSI (Relative Strength Index) is 75.01 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 15.16, which suggests the price will increase in the coming days. Percent R is at 11.31%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
